Acute Mild Pancreatitis Following COVID-19 mRNA Vaccine in an Adolescent.
Ahmad KantarManuela SeminaraMarta OdoniIlaria Dalla VerdePublished in: Children (Basel, Switzerland) (2021)
A 17-year-old male was referred to the emergency room with sharp abdominal pain, pallor, sweating, and vomiting 12 h after the administration of his first Pfizer-BioNTech vaccine for coronavirus disease 2019 (COVID-19). He had abdominal pain, an increase in serum lipase value of > 3 times the upper limits of normal, and magnetic resonance imaging (MRI) findings consistent with acute mild pancreatitis (AP). He was started on treatment with fluid therapy and non-steroidal anti-inflammatory drugs for pain management, after which he recovered rapidly and was discharged on the fourth day after hospitalization. The available data are difficult to interpret as AP is a relatively frequent disease, but its occurrence after vaccination seems extremely rare. Although it is a rare event, AP should be considered after COVID-19 vaccination, especially in those exhibiting abdominal tenderness and vomiting, which should be promptly treated and adequately investigated.
Keyphrases
- abdominal pain
- coronavirus disease
- anti inflammatory drugs
- pain management
- magnetic resonance imaging
- sars cov
- liver failure
- transcription factor
- respiratory syndrome coronavirus
- respiratory failure
- emergency department
- computed tomography
- drug induced
- healthcare
- contrast enhanced
- chronic pain
- young adults
- aortic dissection
- risk assessment
- public health
- mental health
- combination therapy
- deep learning
- mass spectrometry
- intensive care unit
- atomic force microscopy
- electronic health record
- magnetic resonance
- bone marrow
- high speed
- cell therapy
- acute respiratory distress syndrome